139 related articles for article (PubMed ID: 7165995)
1. The effect of intravenous Corynebacterium parvum on gut associated mononuclear phagocytes in normal and tumour bearing rats.
Souter RG; Steer HW
Clin Exp Immunol; 1982 Dec; 50(3):487-94. PubMed ID: 7165995
[TBL] [Abstract][Full Text] [Related]
2. Effect of adriamycin and Corynebacterium parvum in tumor-bearing mice: modulation of response to sheep red blood cells.
Dimitrov NV; Denny TN; Weisman MF; Cameron DG
J Natl Cancer Inst; 1979 Aug; 63(2):423-6. PubMed ID: 379400
[TBL] [Abstract][Full Text] [Related]
3. Measurement of phagocytic activity of reticuloendothelial system (RES) by Intralipid: effect of C parvum treatment.
Kim DK; Pfeifer J
Surg Forum; 1977; 28():85-7. PubMed ID: 617547
[No Abstract] [Full Text] [Related]
4. The effect of Corynebacterium parvum on human effector cells in peripheral blood.
Gill PG; Waller CA; Clarke J; Darley J; Morris PJ
Dev Biol Stand; 1977 Apr 13-15; 38():455-60. PubMed ID: 608538
[No Abstract] [Full Text] [Related]
5. The effects of interferon on the recirculation of lymphocytes in the rat.
Kimber I; Sparshott SM; Bell EB; Ford WL
Immunology; 1987 Apr; 60(4):585-91. PubMed ID: 3583313
[TBL] [Abstract][Full Text] [Related]
6. Elevation of infiltrating mononuclear phagocytes in human colorectal tumors.
Allen C; Hogg N
J Natl Cancer Inst; 1987 Mar; 78(3):465-70. PubMed ID: 3546908
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity and lymphoreticular stimulation properties of fractions isolated from Corynebacterium parvum.
Cantrell JL; Wheat RW
Cancer Res; 1979 Sep; 39(9):3554-63. PubMed ID: 225023
[No Abstract] [Full Text] [Related]
8. IgA antibodies in the bile of rats. V. Primacy of the GALT as a source of IgA.
Gyure LA; Hall JG; Hobbs SM; Jackson LE
Immunology; 1991 Jan; 72(1):85-8. PubMed ID: 1997404
[TBL] [Abstract][Full Text] [Related]
9. [Passive transfer of "Corynebacterium parvum" anti-tumour protection by stimulated peritoneal cells ].
Mazurek C; Stiffel C; Chalvet H; Biozzi G
Ann Immunol (Paris); 1981; 132D(1):43-54. PubMed ID: 6896973
[TBL] [Abstract][Full Text] [Related]
10. Active immunization of rats against two tumoral ascites using live cells associated with Corynebacterium parvum.
Lupu A
Arch Roum Pathol Exp Microbiol; 1987; 46(2):167-71. PubMed ID: 3455654
[No Abstract] [Full Text] [Related]
11. Entry of monocytes into the brain after injection of Corynebacterium parvum.
Cheng L; Allore RJ; Richardson PM
Exp Neurol; 1998 Feb; 149(2):322-8. PubMed ID: 9500970
[TBL] [Abstract][Full Text] [Related]
12. Corynebacterium parvum enhances colonic cancer in dimethylhydrazine-treated rats.
Cruse JP; Lewin MR; Clark CG
Br J Cancer; 1978 Apr; 37(4):639-43. PubMed ID: 646934
[No Abstract] [Full Text] [Related]
13. Relationship between phagocytic activity of macrophages and delayed footpad reaction against syngeneic testicular cells.
Nomoto K; Yoshikai Y; Yoshida S; Miake S
J Clin Lab Immunol; 1982 Feb; 7(2):141-6. PubMed ID: 7069784
[TBL] [Abstract][Full Text] [Related]
14. Modulation of macrophage functions by corynebacterium parvum preparations.
Bonina L; Delfino D; Costa GB; Arena A
Boll Ist Sieroter Milan; 1989; 68(1):62-6. PubMed ID: 2491287
[TBL] [Abstract][Full Text] [Related]
15. The reversal of surgically induced reticuloendothelial depression.
Everson NW; Stacey RL; Wood RF; Bell PR
Clin Exp Immunol; 1979 Jul; 37(1):169-73. PubMed ID: 487654
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulation by corynebacterium parvum in two strains of guinea-pigs and the effect of cyclophosphamide.
Gauthier-Rahman S
Immunology; 1981 Jan; 42(1):99-109. PubMed ID: 7461727
[TBL] [Abstract][Full Text] [Related]
17. The effect of Corynebacterium parvum on the humoral and cellular immune systems in patients with breast cancer.
Minton JP; Rossio JL; Dixon B; Dodd MC
Clin Exp Immunol; 1976 Jun; 24(3):441-7. PubMed ID: 1084821
[TBL] [Abstract][Full Text] [Related]
18. Effect of Corynebacterium parvum on cytotoxicity of regional and nonregional lymph node cells from animals with tumors present or removed.
Fisher B; Wolmark N; Coyle J
J Natl Cancer Inst; 1974 Dec; 53(6):1793-801. PubMed ID: 4471644
[No Abstract] [Full Text] [Related]
19. Haematological changes and iron metabolism in rats after administration of Corynebacterium parvum.
Brozovic B; Sljivić VS; Warr GW
Br J Exp Pathol; 1975 Apr; 56(2):183-92. PubMed ID: 1203175
[TBL] [Abstract][Full Text] [Related]
20. Corynebacterium parvum: antibodies measured with the enzyme-linked immunosorbent assay (ELISA) in normal human sera and sera from cancer patients undergoing treatment.
Ruitenberg EJ; Buys J; Ursem PS
Ann Immunol (Paris); 1982; 133D(3):305-11. PubMed ID: 7165281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
